Merchavia Holdings and Investments Ltd. has made many investments in yield-bearing real estate over the years.
While rethinking the business strategy employed by the company’s board of directors in 2014, a decision was made to gradually exit the company’s investments in real estate and to begin investing in life science.
Merchavia Life Science Business Strategy
Invest in technologies and platforms with high potential for development and commerce of products in leading fields of medicine.
Unique deal flow
Invest in companies, technologies and medical products while collaborating with leading international companies and building unique strategic ties.
Invest in medical solutions that are in demand and have high market potential.
We believe in focus
clearly focused investments, preferably while joining a leading strategic entity.
Share Holding Structure
Merchavia is a public traded in tase
On 30/06/15 the shares allocation have been:
25.52% – The public
74.48% – Entities related and controlled by Goldstein Family and traded on the Tel Aviv Stock Exchange. [ Read More…]
Owners of an exceptionally broad-scale family real estate company in the USA. Several years ago, the family decided to invest in Israel and purchased a public company for tens of millions of NIS.
The Board Members
Certified lawyer (USA) and senior manager in the Goldstein family global business of real estate and growth companies.
Manager of the Goldstein business in Israel .Holds more than 20 years of senior positions, mostly in the real estate business.
Has been a director of the SHL Telemedicine (ticker SHLTN ) since its inception. Prior to his current position as Co-CEO he served as SHL Israel’s managing director. Mr. Alroy holds an MBA from the Hebrew University of Jerusalem.
Holds LL.B. Law (2006) an is an active attorney since 2007. Yaron is a senior attorney at Glusman & Co. legal firm and is in charge of various aspects of commercial law.
With more than 15 years experience in a senior positions, as a Chief Financial Officer.
The Board Members
Eli Arad | CEO
Mr. Arad has served as CFO in Numerous public companies as D medical Industries, Bio-Cell, Biomedix Incubator ETC.. Eli has vast experience with Israeli startups and has served in numerous leading roles in the Israeli start-up sector. Eli has broad experience in all aspects of ﬁnancial management as well as experience with Leading private and public placements by institutional investors and private investors. Eli worked at PWC Israel for almost 7 years.
Rani Lifshitz | Chairman of the Board
Attorney and economist with over 20 years of experience in various senior management positions in the fields of finance and energy in Israel and around the world.